Area of research
Molecular Biology · Biomedical Engineering
Research interest
Research interests include Nanoplatforms for cancer theranostics, RNA Interference and Gene Delivery, Nanoparticle-Based Drug Delivery, and Advanced biosensing and bioanalysis techniques.
Nanoparticle-mediated targeting chimeras transform targeted protein degradation
High-Throughput Generation of Tumor Spheroids via Droplet Microfluidics for siRNA-Loaded Nanomedicine Assessment.
Non-Invasive Brain Targeted Delivery of Cannabidiol for Alleviating Neuroinflammatory Disease.
Restoration of p53 mRNA combined with BRD4 silencing by brain targeted nanocapsules achieves effective combinatorial treatment of glioblastoma.
Clinical translation of nanomedicines for brain diseases: Current challenges and future directions.
Two-dimensional NIR-II AIE nanotheranostic probes with ultralarge Stokes shifts for surgical navigation and ablation of glioma.
Advances in targeted protein degradation for cancer immunotherapy
Artificial-intelligence-driven rational design of nanoparticle-mediated targeted protein degradation
Biomimetic Nanovaccine Integrating Dendritic Cell Exosomes with Tumor Cell Membranes for Sustained Prophylaxis Against Glioblastoma
A Brain-Targeting NIR-II Polymeric Phototheranostic Nanoplatform toward Orthotopic Drug-Resistant Glioblastoma.
Glioblastoma Cell Derived Exosomes as a Potent Vaccine Platform Targeting Primary Brain Cancers and Brain Metastases.
Advanced nanoparticle engineering for precision therapeutics of brain diseases.
Inhibition of ICAM1 diminishes stemness and enhances antitumor immunity in glioblastoma via β-catenin/PD-L1 signaling.
Amino acid transporters mediate autonomous delivery of nanoparticle vehicles into living plants.
Glycyrrhetinic acid functionalized polyamidoamine dendrimers for targeted gene delivery in liver cancer.
Natural Ginger-Derived Exosomes as Effective Therapeutics for Glioblastoma.
Tannic Acid-Iron Complex-Based Nanozyme Ameliorates Parkinson's Disease via Relieving Oxidative Stress and Neuroinflammation.
MAGL targeted PROTAC degrader simultaneously enhances P53 for synergistic treatment of glioblastoma stem cell.
Integrated proteogenomic characterization of glioblastoma evolution
Targeted protein degradation via cellular trafficking of nanoparticles
Integrated proteogenomic characterization of glioblastoma evolution.
A one-two punch targeting reactive oxygen species and fibril for rescuing Alzheimer's disease.
Bio-Nano Toolbox for Precision Alzheimer's Disease Gene Therapy.
CD97 maintains tumorigenicity of glioblastoma stem cells via mTORC2 signaling and is targeted by CAR Th9 cells.
Small Scale, Big Impact: Nanotechnology-Enhanced Drug Delivery for Brain Diseases.
Exosomes based strategies for brain drug delivery.
Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment.
Near-Infrared Aggregation-Induced Emission Luminogens for In Vivo Theranostics of Alzheimer's Disease.
Liquid-liquid phase separation of amyloid-β oligomers modulates amyloid fibrils formation.
IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis.